Status:
COMPLETED
Lormetazepam Versus Midazolam in Critically Ill Patients: a Retrospective Cohort Trial
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this retrospective cohort study is to evaluate the effect of lormetazepam versus midazolam on hospital mortality, intensive care unit outcomes and sedation management. The hypothesis is th...
Detailed Description
Sedation is an integral part of modern intensive care medicine and has seen a tremendous development throughout the last years. Current guideline recommendations are targeted at an awake critically il...
Eligibility Criteria
Inclusion
- Intensive care unit patients at the Charité - Universitätsmedizin Berlin
- Age ≥ 18 years
- Intensive care unit length of stay ≥ 48 hours
- Duration of mechanical ventilation \> 0 hours
- Midazolam or lormetazepam application during the ICU stay
Exclusion
- Number of application \< 2
- Midazolam and lormetazepam application during the intensive care unit stay
- Neurosurgical intensive care unit patients
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
3314 Patients enrolled
Trial Details
Trial ID
NCT04408911
Start Date
January 1 2006
End Date
December 31 2018
Last Update
May 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.